277 related articles for article (PubMed ID: 18520605)
1. Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
Neuvonen M; Neuvonen PJ
Ther Drug Monit; 2008 Jun; 30(3):333-40. PubMed ID: 18520605
[TBL] [Abstract][Full Text] [Related]
2. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
[TBL] [Abstract][Full Text] [Related]
3. Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
Edwards SR; Smith MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):264-70. PubMed ID: 17098487
[TBL] [Abstract][Full Text] [Related]
4. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.
Fang WB; Lofwall MR; Walsh SL; Moody DE
J Anal Toxicol; 2013; 37(6):337-44. PubMed ID: 23743505
[TBL] [Abstract][Full Text] [Related]
5. Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.
Pantano F; Brauneis S; Forneris A; Pacifici R; Marinelli E; Kyriakou C; Pichini S; Busardò FP
Clin Chem Lab Med; 2017 Aug; 55(9):1324-1331. PubMed ID: 28080998
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of polar analytes using column-switching: application to oxycodone and three metabolites in human plasma.
Wagner M; Bourgogne E; Varesio E; Hopfgartner G
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):637-44. PubMed ID: 20138595
[TBL] [Abstract][Full Text] [Related]
7. Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry.
Gaudette F; Sirhan-Daneau A; St-Onge M; Turgeon J; Michaud V
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():174-180. PubMed ID: 26655109
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of morphine, oxycodone, morphine-3-glucuronide, and noroxycodone concentrations in rat serum by high performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
Edwards SR; Smith MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):241-9. PubMed ID: 15639445
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Chan S; Edwards SR; Wyse BD; Smith MT
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography.
Cheremina O; Bachmakov I; Neubert A; Brune K; Fromm MF; Hinz B
Biomed Chromatogr; 2005 Dec; 19(10):777-82. PubMed ID: 15920700
[TBL] [Abstract][Full Text] [Related]
11. Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples.
Favretto D; Frison G; Vogliardi S; Ferrara SD
Rapid Commun Mass Spectrom; 2006; 20(8):1257-65. PubMed ID: 16550495
[TBL] [Abstract][Full Text] [Related]
12. Sensitive quantification of apomorphine in human plasma using a LC-ESI-MS-MS method.
Abe E; Alvarez JC
Ther Drug Monit; 2006 Jun; 28(3):407-12. PubMed ID: 16778727
[TBL] [Abstract][Full Text] [Related]
13. A sensitive LC-MS/MS method for the quantitation of oxycodone, noroxycodone, 6α-oxycodol, 6β-oxycodol, oxymorphone, and noroxymorphone in human blood.
Truver MT; Jakobsson G; Chermà MD; Swortwood MJ; Gréen H; Kronstrand R
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 May; 1171():122625. PubMed ID: 33744597
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
Kaiko RF; Benziger DP; Fitzmartin RD; Burke BE; Reder RF; Goldenheim PD
Clin Pharmacol Ther; 1996 Jan; 59(1):52-61. PubMed ID: 8549034
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a liquid chromatographic/tandem mass spectrometric assay for the quantitation of nucleoside HIV reverse transcriptase inhibitors in biological matrices.
Compain S; Schlemmer D; Levi M; Pruvost A; Goujard C; Grassi J; Benech H
J Mass Spectrom; 2005 Jan; 40(1):9-18. PubMed ID: 15643642
[TBL] [Abstract][Full Text] [Related]
16. Determination of alprostadil in rat plasma by ultra performance liquid chromatography-electrospray ionization-tandem mass spectrometry after intravenous administration.
Lin X; Zhang Y; Cui Y; Wang L; Wang J; Tang X
J Pharm Biomed Anal; 2009 May; 49(4):983-8. PubMed ID: 19217739
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of simvastatin and its beta-hydroxy acid in human plasma by liquid-liquid cartridge extraction and liquid chromatography/tandem mass spectrometry.
Zhao JJ; Xie IH; Yang AY; Roadcap BA; Rogers JD
J Mass Spectrom; 2000 Sep; 35(9):1133-43. PubMed ID: 11006608
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of zidovudine diaryl phosphate triester pro-drugs in rat plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Zhu M; Xie B; Tang G; Hu A; Fang M; Wu Z; Zhao Y
J Pharm Biomed Anal; 2008 Dec; 48(5):1417-24. PubMed ID: 19118970
[TBL] [Abstract][Full Text] [Related]
19. Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence study.
Bhaumik U; Ghosh A; Sarkar AK; Bose A; Selvan PS; Sengupta P; Chakraborty US; Ghosh D; Pal TK
J Pharm Biomed Anal; 2008 Dec; 48(5):1404-10. PubMed ID: 18986788
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of oxymorphone and its active metabolite 6-OH-oxymorphone in human plasma by high performance liquid chromatography-tandem mass spectrometry.
Zha W; Shum L
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():116-21. PubMed ID: 22795571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
